Innovation Exchange Amsterdam (IXA) helps drive the transition of academic and practice-based research and knowledge into ground-breaking innovations and applications that improve lives, transform industries, and create substantial societal and economic value.
It all started in 2014 when the University of Amsterdam (UvA), Amsterdam University of Applied Sciences (HvA), Vrije Universiteit (VU) Amsterdam and Amsterdam UMC joined forces and combined their so-called knowledge transfer offices (KTO) to form Innovation Exchange Amsterdam (IXA).
IXA is the expert interface between Amsterdam-based universities and parties interested in their research findings and knowledge. Being an interface, IXA deploys its expertise in two directions:
In addition, IXA supports UvA, HvA, VU, Amsterdam UMC, AHK and KNAW management and teaching and supporting staff (HRM, legal, financial, administrative, secretarial and communication) seeking expertise or advice on research-based entrepreneurship, and research funding and grants.
At every campus location throughout Amsterdam, our business developers, legal advisors and grant advisors contribute to developing the Amsterdam innovation ecosystem by bringing people together. Meet the IXA Teams.
IXA offices are an integral part of the universities’ service infrastructure. Therefore, our services, facilities and expertise are free of charge.
Teachers from the department of medical informatics of Amsterdam UMC have developed an online platform to gather and visualize structured curriculum information, called act-E. Education managers, teachers and students use this platform to gain insights regarding their curricula that could never be viewed as easily before. These insights help them to have an informed conversation […]News
VU alumni International Business Administration Michael Musandu and Ugnius Rimsa founded Lalaland in 2019. The startup generates and hyper personalizes full human body models from head to toe by using AI. As a result, models are available in different ethnicities, sizes and ages, allowing customers to always recognize themselves in the clothing of their choice. […]News
Chronic kidney diseases are a severe and growing worldwide problem with a lack of effective treatments often leading to dialysis, transplantation, and high costs to health care systems. Now, a monoclonal antibody, named BION-1301 (anti-APRIL), is being developed to treat patients with IgA nephropathy. BION-1301 is a potential disease-modifying approach to prevent the formation of […]News